Keystone Heart accelerate trials for third-generation of its TriGuard device

Keystone Heart has announced plans to initiate clinical trials for a new, advanced version of its TriGuard cerebral embolic protection device. A press release...

CE mark for CoreValve Evolut Pro

Medtronic has received the CE mark for its CoreValve Evolut Pro valve for the treatment of severe aortic stenosis for symptomatic patients who are...

4C Medical receives over US$8 million financing for transcatheter mitral regurgitation treatment

4C Medical has received approximately US$9 million in unsecured convertible promissory notes. The company is focused on the development of minimally invasive therapies for...

EuroPCR 2017: A “golden era” for valve disease therapies

At this year’s EuroPCR (16–19 May, Paris, France), Philip MacCarthy writes, I had the pleasure of welcoming onto the podium a team of determined cyclists...

Vinayak Bapat

Rebecca Hahn

Ran Kornowski